John T. Bates
Affiliations: | 2010-2013 | Pediatrics | Vanderbilt University School of Medicine, Nashville, TN, United States |
Google:
"John Bates"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bates JT, Farmer AP, Bierdeman MA, et al. (2022) IgG Antibody Response to the Pfizer BNT162b2 SARS-CoV-2 Vaccine in Healthcare Workers with Healthy Weight, Overweight, and Obesity. Vaccines. 10 |
| Pramanik A, Sharma PC, Patibandla S, et al. (2022) Blocking SARS-CoV-2 Delta Variant (B.1.617.2) Spike Protein Receptor-Binding Domain Binding with the ACE2 Receptor of the Host Cell and Inhibiting Virus Infections Using Human Host Defense Peptide-Conjugated Graphene Quantum Dots. Acs Omega. 7: 8150-8157 |
| Shalaby A, Laharwani H, Bates JT, et al. (2021) Efficacy of POC Antibody Assays after COVID-19 Infection and Potential Utility for "Immunity Passports". Laboratory Medicine |
| Mitra D, Hasan MH, Bates JT, et al. (2021) The degree of polymerization and sulfation patterns in heparan sulfate are critical determinants of cytomegalovirus entry into host cells. Plos Pathogens. 17: e1009803 |
| Yan L, Song Y, Xia K, et al. (2021) Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus. Carbohydrate Polymers. 260: 117797 |
| Tandon R, Mitra D, Sharma P, et al. (2020) Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein. Scientific Reports. 10: 19076 |
| Sesterhenn F, Yang C, Bonet J, et al. (2020) De novo protein design enables the precise induction of RSV-neutralizing antibodies. Science (New York, N.Y.). 368 |
| Wen X, Mousa JJ, Bates JT, et al. (2017) Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus. Nature Microbiology. 2: 16272 |
| Mousa JJ, Sauer MF, Sevy AM, et al. (2016) Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proceedings of the National Academy of Sciences of the United States of America |
| Bates JT, Pickens JA, Schuster JE, et al. (2016) Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates. Vaccine |